Real-World Evidence: ‘Labor-Intensive’ Data Standardization May Be Required By US FDA

Standardizing real-world data to fit US Food and Drug Administration requirements can be difficult, and new guidance suggests a less-labor intensive solution may not be ideal when the information is intended to show safety or efficacy.

Since claims, electronic health record and other real-world data often are formatted differently than the agency requires, FDA expects sponsors...